SPONSOR
Universitätsklinikum Hamburg-Eppendorf
Total Trials
7
Recruiting
7
Phases
N/A
Conditions studied: NeoplasmsStroke, IschemicSoft Tissue Sarcoma (STS)This Study Aims to Evaluate the Safety Profile and Tissue Changes After Biostimulatory Treatments to the Face in Healthy VolunteersPostinduction HypotensionMetastatic MelanomaAdvanced Cancer, Various, NOS
Universitätsklinikum Hamburg-Eppendorf is a clinical research sponsor with 7 registered studies on ClinicalTrials.gov, of which 7 are actively recruiting participants. Research covers conditions including Neoplasms, Stroke, Ischemic, Soft Tissue Sarcoma (STS), This Study Aims to Evaluate the Safety Profile and Tissue Changes After Biostimulatory Treatments to the Face in Healthy Volunteers.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Universitätsklinikum Hamburg-Eppendorf
How many clinical trials has Universitätsklinikum Hamburg-Eppendorf sponsored?
ClinicalMetric currently tracks 7 clinical trials sponsored by Universitätsklinikum Hamburg-Eppendorf, of which 7 are actively recruiting participants. These trials cover conditions including Neoplasms, Stroke, Ischemic, Soft Tissue Sarcoma (STS). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Universitätsklinikum Hamburg-Eppendorf research focus on?
Universitätsklinikum Hamburg-Eppendorf clinical trials span Neoplasms, Stroke, Ischemic, Soft Tissue Sarcoma (STS), This Study Aims to Evaluate the Safety Profile and Tissue Changes After Biostimulatory Treatments to the Face in Healthy Volunteers, Postinduction Hypotension, and additional conditions. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Universitätsklinikum Hamburg-Eppendorf clinical trial?
To participate in a Universitätsklinikum Hamburg-Eppendorf trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Universitätsklinikum Hamburg-Eppendorf trials with current recruitment status updated daily.
Clinical Trials by Universitätsklinikum Hamburg-Eppendorf
NCT07200453
Recruiting
Evaluation of an Interactive E-learning Environment to Enhance Digital Health Literacy in Cancer Patients
Neoplasms
NCT05560724
Recruiting
Network Properties As Biomarkers for Non-Invasive Brain Stimulation (NIBS) After Stroke
Stroke, Ischemic
NCT06889532
Recruiting
SAVE Studie- SArcoma Surgery With Vacuum Enhanced Wound Treatment Randomised Study to Evaluate the Wound Management in Sarcoma Surgery
Soft Tissue Sarcoma (STS)
NCT06993558
Recruiting
Analysis of Safety and Tissue Interaction of Injectable and Energy-based Biosmulators
This Study Aims to Evaluate the Safety Profile and Tissue Changes After Biostimulatory Treatments to the Face in Healthy Volunteers
NCT07538388
Recruiting
Continuous Versus Bolus Norepinephrine Administration to Treat Postinduction Hypotension
Postinduction Hypotension
NCT07564570
Recruiting
Physical Activity Directly Before Immunotherapy (Nivolumab and Ipilimumab) in Melanoma
Metastatic Melanoma
NCT07312760
Recruiting
Existential Distress in Advanced Cancer: Comparing a Short-term Psychodynamic Psychotherapy (ORPHYS) to Treatment as Usual (TAU)
Advanced Cancer, Various, NOS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology